ClinicalTrials.gg
RecruitingNCT06525987TELECONNECTUpdated Dec 2, 2025

Telecoached Exercise Intervention for Connectivity Enhancement in Small Vessel Disease (TELECONNECT-SVD)

An interventional study of Physical activity in Lacunar Stroke and Small Vessel Cerebrovascular Disease, sponsored by University of L'Aquila. Recruiting at 1 site in Italy. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-12-02.

Sponsored by University of L'Aquila · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The TELECONNECT-SVD study is a prospective, randomized, multicenter trial aimed at testing the efficacy of a remotely delivered exercise protocol on brain functional connectivity in patients with small vessel disease (SVD)-related ischemic stroke. The study will recruit patients aged ≥60 with a history of lacunar stroke, minimal disability (modified Rankin Scale score 0-1), and low physical activity levels.

The trial will include 60 participants randomized 1:1 to either a 24-week telecoached exercise intervention or usual care. The exercise program consists of multicomponent physical exercises delivered remotely twice a week. Assessments will be conducted at baseline, 12 weeks, 24 weeks, and 48 weeks.

Primary outcomes include changes in brain functional connectivity assessed by high-density EEG and improvements in physical fitness measured by the Senior Fitness Test. Secondary outcomes encompass changes in physical activity levels, anthropometric measurements, and vital signs.

The study employs a "wait list" design, where the control group receives the intervention after the initial 24-week period. This approach allows for assessment of the intervention's immediate effects and the retention of benefits after cessation.

Key features of the protocol include:

  • Use of telecoaching to enhance adherence to the exercise program
  • Comprehensive assessment of brain connectivity using advanced EEG analysis techniques
  • Focus on patients with SVD, who may benefit significantly from exercise interventions
  • Evaluation of both neurophysiological and clinical outcomes

The study aims to provide evidence for the potential benefits of exercise in enhancing brain connectivity and physical fitness in SVD patients, potentially informing future treatment guidelines and preventive strategies for this population.

02

Conditions studied

  • Lacunar Stroke
  • Small Vessel Cerebrovascular Disease
03

In context

Stroke, Lacunar

21 studies on the registry are indexed under Stroke, Lacunar; 9 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 15 interventional studies indexed under Stroke, Lacunar.

Browse Stroke, Lacunar studies →

Lead sponsor

University of L'Aquila is the lead sponsor of 46 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥60 years;
  • History of lacunar stroke occurred between 3 months and 10 years from screening and confirmed by neuroimaging or clinical data by an expert stroke physician;
  • Modified Rankin Scale (mRS) score of 0-1, indicating no symptoms or no significant disability;
  • A level of physical activity below recommended targets, i.e. \<150 minutes per week of moderate-to-vigorous exercise (24);
  • Ability to sign .

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled hypertension;
  • Heart disease impairing the possibility of safely following an exercise protocol at the discretion of the treating physician;
  • Primary or secondary epilepsy;
  • Prostheses, implants, and any device that might impair the performance of either high-density electroencephalogram or the exercise intervention;
  • Cognitive impairment ( score ≤26 at follow-up);
  • Lack of access to Internet-based facilities or poor technological alphabetization impairing the adherence to the trial protocol;
  • Any major physical or psychiatric comorbidity that in the judgement of the treating physician might compromise the ability to undergo an exercise intervention.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Immediate intervention

    Participants will be allocated to physical activity intervention during the 24 weeks of follow-up.

    Behavioral: Physical activity

  • Other
    Delayed intervention

    Participants will not be randomized to physical activity intervention during the first 24 weeks of follow-up. They will be randomized after the 24 weeks of follow-up.

    Behavioral: Physical activity

Interventions

  • BehavioralPhysical activity

    Randomization to a 24-week physical exercise program

    Also known as: Physical activity (delayed)

06

What researchers measure

Primary outcomes

  1. Change in Senior Fitness Test score

    Change in the Senior Fitness score from before to after the 24-week physical exercise intervention

    Time frame: 24 weeks

Secondary outcomes

  1. Change in International Physical Activity Questionnaire (IPAQ) score

    Change in International Physical Activity Questionnaire (IPAQ) score from before to after the 24-week physical exercise intervention

    Time frame: 24 weeks

  2. Change in Body Mass Index

    Change in Body Mass Index score from before to after the 24-week physical exercise intervention

    Time frame: 24 weeks

  3. Change in blood pressure

    Change in blood pressure from before to after the 24-week physical exercise intervention

    Time frame: 24 weeks

  4. Change in heart rate

    Change in heart rate from before to after the 24-week physical exercise intervention

    Time frame: 24 weeks

Other outcomes

  1. Change in brain functional connectivity

    Overall brain functional connectivity in the resting state assessed via high-density electroencephalogram

    Time frame: 24 weeks

07

Study locations

1 of 1 sites recruiting
  • UOC Neurologia e Stroke Unit
    Avezzano, L'Aquila 67051, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD will be available from the central contact person upon reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for Dec 2026, 19 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2024
First posted
Jul 29, 2024
StartActual
May 2, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Dec 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06525987
Lead sponsor
University of L'Aquila
Responsible party
Simona Sacco (Full Professor of Neurology, University of L'Aquila) — Principal investigator
First posted
Jul 29, 2024
Start date
May 2, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Dec 2, 2025

Study contacts

Raffaele Ornello, MD, PhD
Contact
raffaele.ornello@univaq.it
+390863499322

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion